Period Ending: |
LTM
(Last Twelve Months) |
2024 12-31 |
2023 12-31 |
2022 12-31 |
---|---|---|---|---|
Report Filing | 2025-05-20 | 2025-04-14 | 2024-04-16 | 2023-03-31 |
Revenue | 0 | 0 | 0 | 0 |
Cost of Revenue | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 |
Operating Expenses | 0.812 | 0.871 | 0.676 | 0.081 |
Research & Development | 0 | 0 | 0 | 0 |
Selling, General and Administrative | 0.451 | 0 | 0.676 | 0.081 |
Other Operating Expenses | 0.361 | 0.871 | -0 | 0 |
Operating Income | -0.812 | -0.871 | -0.676 | -0.081 |
Net Non-Operating Interest | 2.18 | 0 | 0 | 0.038 |
Interest Income | 2.18 | 0 | 0 | 0.038 |
Interest Expense | 0 | 0 | 0 | 0 |
Equity & Other Income/(Expense) | -0 | 3.05 | 3.58 | 0 |
Income Before Tax | 1.37 | 2.18 | 2.9 | -0.043 |
Income Tax Expense | 0 | 0.469 | 0 | -0 |
Income Attributable to Non-Controlling Interest | -0.131 | -0.469 | 0 | 0 |
Net Income | 1.5 | 2.18 | 2.9 | -0.043 |
Depreciation and Amortization | -0.237 | 0 | 0 | 0.081 |
EBITDA | -1.05 | -0.871 | -0.676 | 0 |
Earnings Per Share (EPS) | 0.415 | 0.47 | 0.32 | -0.005 |
Diluted Earnings Per Share | 0.375 | 0.47 | 0.32 | -0.005 |
Weighted Average Shares Outstanding | 2.28 | 3.85 | 9.15 | 9.18 |
Diluted Weighted Average Shares Outstanding | 3.85 | 3.85 | 9.15 | 9.18 |